{"id":3504,"date":"2025-09-05T16:54:12","date_gmt":"2025-09-05T07:54:12","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/member_search\/3504"},"modified":"2025-09-05T16:54:12","modified_gmt":"2025-09-05T07:54:12","slug":"Adlinda-Alip","status":"publish","type":"researcher","link":"https:\/\/atlas.ncc.go.jp\/en\/member_search\/3504","title":{"rendered":"Adlinda Alip EN"},"template":"","class_list":["post-3504","researcher","type-researcher","status-publish","hentry","en-US"],"acf":{"name_eg":"Adlinda Alip","familyName_eg":"Alip","has_jp_name":false,"name_jp":"","researcher_photo":1405,"participated_in":["-1"],"degree":"BM, MRCP, FRCR","position":"Associate Professor","eg_position":"Associate Professor","facilities":3464,"department":["7"],"speciality":"Systemic therapy, SRS\/SBRT","eg_speciality":"Systemic therapy, SRS\/SBRT","background":"<h2><strong>Dr. Adlinda Alip's Story<\/strong><\/h2>\r\n<p>I was trained in UK. After completing Clinical Oncology training in UK, I joined University Malaya as Senior Lecturer and Clinical Oncologist. I am involved in undergraduate education and Master in Clinical Oncology programme, which is the only one programme in Malaysia. I am a coordinator for research for the Master trainees.<\/p>\r\n<h2><strong>Research Interest<\/strong><\/h2>\r\n<p>My research interest is in Lung SBRT. Involved in clinical studies for Lung, Breast Cancer and Genitourinary Cancers, including phase 2 and 3 trials.<\/p>\r\n<h2><strong>Professional Experience<\/strong><\/h2>\r\n<table class=\"table1\" style=\"border-collapse: collapse; width: 100%; height: 50px;\">\r\n<tbody>\r\n<tr style=\"height: 48px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">06\/04\/2020 to present<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">Curriculum committee, FACULTY,\u202fUniversity Malaya<\/td>\r\n<\/tr>\r\n<tr style=\"height: 48px;\">\r\n<td style=\"width: 22.2887%; height: 12px;\">12\/09\/2017 to present<\/td>\r\n<td style=\"width: 77.5977%; height: 12px;\">Mentor,\u202fFaculty<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 22.2887%; height: 18px;\">06\/03\/2019 to 05\/03\/2021<\/td>\r\n<td style=\"width: 77.5977%; height: 18px;\">Head,\u202fClinical Oncology Dept, UNIVERSITI MALATA<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">04\/04\/2021 to 05\/04\/2021<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">Member of Advisory Development of Guidelines for Centre of Excellence (COE) in Healthcare Facility in Malaysia<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<h2>Specialized field<\/h2>\r\n<p>Clinical Oncology<\/p>\r\n<h2>Specialized treatment<\/h2>\r\n<p>Systemic therapy, SRS\/SBRT<\/p>\r\n<h2>Specialized organ<\/h2>\r\n<p>Lung, Breast, Genitourinary, CNS tumour<\/p>\r\n<h2>Qualifications, certified physicians, medical specialists<\/h2>\r\n<p>FRCR (Clinical Oncology),\u202fKLINIKAL ONKOLOGI,\u202fROYAL COLLEGE OF RADIOLOGIST, LONDON <br \/>\r\nMRCP,\u202fMEDICINE,\u202fROYAL COLLEGE OF PHYSICIANS, UNITED KINGDOM <br \/>\r\nBMed,\u202fMEDICINE,\u202fSOUTHAMPTON UNIVERSITY, UK<\/p>","eg_background":"<h2><strong>Dr. Adlinda Alip's Story<\/strong><\/h2>\r\n<p>I was trained in UK. After completing Clinical Oncology training in UK, I joined University Malaya as Senior Lecturer and Clinical Oncologist. I am involved in undergraduate education and Master in Clinical Oncology programme, which is the only one programme in Malaysia. I am a coordinator for research for the Master trainees.<\/p>\r\n<h2><strong>Research Interest<\/strong><\/h2>\r\n<p>My research interest is in Lung SBRT. Involved in clinical studies for Lung, Breast Cancer and Genitourinary Cancers, including phase 2 and 3 trials.<\/p>\r\n<h2><strong>Professional Experience<\/strong><\/h2>\r\n<table class=\"table1\" style=\"border-collapse: collapse; width: 100%; height: 48px;\">\r\n<tbody>\r\n<tr style=\"height: 48px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">06\/04\/2020 to present<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">Curriculum committee, FACULTY,\u202fUniversity Malaya<\/td>\r\n<\/tr>\r\n<tr style=\"height: 48px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">12\/09\/2017 to present<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">Mentor,\u202fFaculty<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 22.2887%; height: 18px;\">06\/03\/2019 to 05\/03\/2021<\/td>\r\n<td style=\"width: 77.5977%; height: 18px;\">Head,\u202fClinical Oncology Dept, UNIVERSITI MALATA<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">04\/04\/2021 to 05\/04\/2021<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">Member of Advisory Development of Guidelines for Centre of Excellence (COE) in Healthcare Facility in Malaysia<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<h2>Specialized field<\/h2>\r\n<p>Clinical Oncology<\/p>\r\n<h2>Specialized treatment<\/h2>\r\n<p>Systemic therapy, SRS\/SBRT<\/p>\r\n<h2>Specialized organ<\/h2>\r\n<p>Lung, Breast, Genitourinary, CNS tumour<\/p>\r\n<h2>Qualifications, certified physicians, medical specialists<\/h2>\r\n<p>FRCR (Clinical Oncology),\u202fKLINIKAL ONKOLOGI,\u202fROYAL COLLEGE OF RADIOLOGIST, LONDON <br \/>\r\nMRCP,\u202fMEDICINE,\u202fROYAL COLLEGE OF PHYSICIANS, UNITED KINGDOM <br \/>\r\nBMed,\u202fMEDICINE,\u202fSOUTHAMPTON UNIVERSITY, UK<\/p>","researcher_outerlink1":"","researcher_outerlink2":"","researcher_outerlink3":"","researcher_outerlink4":"","researcher_outerlink5":"","is_retired":false},"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher\/3504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/researcher"}],"acf:post":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/facility\/3464"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=3504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}